Further, the recent demonstration of the ability of TAAR1 agonists to prevent binge eating allows such compounds to address both the centrally mediated over-consumption and subsequent insulin resistance and hormone imbalance aspects of obesity and associated metabolic disorders [434]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.